Dover has entered into a definitive settlement to acquire Malema Engineering Corp, a US designer and producer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Image: dizain/Adobe Stock.
Malema’s products will increase Dover’s biopharma single-use manufacturing offering, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Soaring , Florida, and with services in San Jose, California, Singapore, South Korea and India, Malema expects to generate roughly US$40 million–45 million in revenue through the full yr 2022.
When the deal closes, Malema will become part of the PSG enterprise unit inside Dover’s Pumps & Process Solutions section.
“We see an amazing long-term progress alternative within the bioprocessing business pushed by a strong and growing pipeline of effective novel biologic drugs, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the growing adoption of extra environment friendly single-use production processes helps a sturdy outlook for our offerings of single-use parts to end-customers. We imagine that pairing Malema’s technology with our existing portfolio of single-use pumps for biopharma processing will significantly enhance the accuracy and worth proposition of our solutions to our clients.”
“We are methodically building out our biopharma platform via proactive capability additions, new product growth, and opportunistic acquisitions of highly-attractive niche part applied sciences,” mentioned Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing expertise and further strengthens our sensor portfolio with new proprietary expertise. In addition to enticing biopharma applications, we count on strong growth within the semiconductor house on the capacity enlargement and re-shoring tailwinds.”
Share